Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

PaperCitations, authors & open-access status

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 569 citations, 2020 year and closed oa status.

569
Citations
2020
Year
closed
OA Status

Related on ScholarIQ

Manabu Morimoto
Author
The Lancet Oncology
Journal
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Cancer Immunotherapy and Biomarkers
Topic
Cholangiocarcinoma and Gallbladder Cancer Studies
Topic
470M+ articles · free account